Clinical Research Directory
Browse clinical research sites, groups, and studies.
Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
Sponsor: Belarusian Research Center for Pediatric Oncology, Hematology and Immunology
Summary
The purpose of this study is to estimate the efficacy of immunotherapy with ex vivo expanded haploidentical NK cells as consolidation therapy for children/young adults with intermediate risk AML.
Official title: Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML
Key Details
Gender
All
Age Range
6 Months - 21 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2021-11-01
Completion Date
2026-06
Last Updated
2024-08-28
Healthy Volunteers
No
Conditions
Interventions
Expanded haploidentical NK cells
Two doses of expanded haploidentical NK cells (30-100 x 10\^6 cells /kg).
Locations (1)
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology
Minsk, Minsk Oblast, Belarus